|
ZNF271 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63491442606301E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.26807461700673E-12 |
| Normal-vs-Stage2 |
2.07699999976718E-07 |
| Normal-vs-Stage3 |
4.75550000000879E-06 |
| Normal-vs-Stage4 |
1.260960E-03 |
| Stage1-vs-Stage2 |
5.431000E-01 |
| Stage1-vs-Stage3 |
3.203400E-01 |
| Stage1-vs-Stage4 |
4.279200E-01 |
| Stage2-vs-Stage3 |
6.756800E-01 |
| Stage2-vs-Stage4 |
5.983600E-01 |
| Stage3-vs-Stage4 |
9.160000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.76996261670138E-14 |
| Normal-vs-AfricanAmerican |
1.11549658399213E-11 |
| Normal-vs-Asian |
2.022599999707E-07 |
| Caucasian-vs-AfricanAmerican |
6.569000E-01 |
| Caucasian-vs-Asian |
2.863200E-01 |
| AfricanAmerican-vs-Asian |
2.319400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62503344114384E-12 |
| Normal-vs-Female |
1.77260000000512E-06 |
| Male-vs-Female |
1.946230E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.55930004861216E-09 |
| Normal-vs-Extreme_Weight |
1.06009645506333E-11 |
| Normal-vs-Obese |
5.03730002154867E-09 |
| Normal-vs-Extreme_Obese |
5.223800E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.147400E-01 |
| Normal_Weight-vs-Obese |
8.779200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.885400E-01 |
| Extreme_Weight-vs-Obese |
5.809000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.558200E-01 |
| Obese-vs-Extreme_Obese |
3.889800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.7987000494889E-09 |
| Normal-vs-Age(41-60Yrs) |
2.46630005307225E-09 |
| Normal-vs-Age(61-80Yrs) |
1.99840144432528E-15 |
| Normal-vs-Age(81-100Yrs) |
1.979860E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.420960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.043200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.620800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.064100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.047020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.362000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.96176408451265E-12 |
| Normal-VS-Type2 PRCC |
4.75575134828432E-12 |
| Normal-VS-KIRP CIMP |
1.04439999981665E-07 |
| Normal-VS-Unclassified PRCC |
2.839400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.807900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.021400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.072400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.770600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.969790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.434200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.08377759491896E-12 |
| Normal-vs-N1 |
8.76050000320205E-08 |
| Normal-vs-N2 |
7.67540000001787E-07 |
| N0-vs-N1 |
9.978400E-01 |
| N0-vs-N2 |
4.413600E-01 |
| N1-vs-N2 |
4.554000E-01 |
|
|
